# Fennec Pharmaceuticals Inc.: Form 8-K, filed Mar 24, 2026

- Company: [Fennec Pharmaceuticals Inc.](/companies/fenc.md) (CIK 1211583)
- Form: 8-K
- Filed: 2026-03-24
- Accepted by EDGAR: Mar 24, 2026, 16:22 ET
- Period: 2026-03-24
- Accession: 0001104659-26-033885
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1211583/000110465926033885/fencf-20260324x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1211583/000110465926033885/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1211583/000110465926033885/fencf-20260324x8k.htm

Filed Mar 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-033885. Last ingested by Listed: Nov 2, 2026, 19:14 ET. No prices; not investment advice.